Rule Pushes Hospitals To Tell Patients About Nursing Home Quality

Sunday, November 27, 2016, 6:24am  By Jordan Rau

Hospitals have long been reluctant to share with patients their assessments of which nursing  homes are best because of a Medicare requirement that patients’ choices can’t be restricted.

For years, many hospitals simply have given patients a list of all the skilled nursing facilities  near where they live and told them which ones have room for a new patient. Patients have  rarely been told which homes have poor quality ratings from Medicare or a history of public  health violations, according to researchers and patient advocates.

“Hospitals are not sure enough that it would be seen as appropriate and so they don’t want to  take the chance that some surveyor will come around to cite them” for violating Medicare’s  rules, said Nancy Foster, vice president for quality and patient safety at the American Hospital  Association.

As a result, patients can unknowingly end up in a nursing home where they suffer bed sores,  infections, insufficient staffing or other types of substandard care.
But hospitals’ tight-lipped approach to sharing quality information may soon be changed. The  Obama administration is rewriting those rules, not just for patients going to nursing homes  but also those headed home or to another type of health facility.

Hospitals will still have to provide patients with all nearby options, but the new rule says  hospitals “must assist the patients, their families, or the patient’s representative in selecting a  post-acute care provider by using and sharing data” about quality that is relevant to a  particular patient’s needs for recovery. The rule was drafted in October 2015.

The administration hasn’t said when it will be finalized. Should it not be enacted before the  end of President Obama’s term, its fate becomes uncertain. President-elect Donald Trump  has pledged not to approve new regulations unless two existing ones are eliminated.
The quality requirement might have made a difference for Elizabeth Fee, an 88-year-old San  Francisco woman who had been hospitalized for a broken hip. Her hospital, California Pacific  Medical Center, told her family about its own nursing home but did not tell them that Medicare  had given it one star, its lowest quality rating, Fee’s family asserts in court papers.

“I feel we were misled because we believed that Mom was going to a facility that would have  given her excellent care,” her daughter Laura Rees said. “And what she got was not even  close to that, it was like night and day.”

At the nursing home, Ms. Fee developed a bowel blockage that went undiagnosed until the  morning of the day she died in January 2012. The nursing home and hospital have denied that  they provided substandard care and declined to comment. The nursing home closed last  year.
Some health systems haven’t waited for Medicare’s rule change to increase the information  they provide patients about prospective nursing homes. In Massachusetts, Partners  Healthcare, which runs Massachusetts General and Brigham and Women’s hospitals – two  teaching hospitals for Harvard University Medical School – endorses 67 nursing homes  around the state based on a host of criteria, including state inspections, readmission rates,  location and how frequently a doctor or nurse practitioner is at the facility.

Partners believes it doesn’t violate Medicare’s rules because it gives departing patients a  complete list of nursing homes while noting on the list which ones are part of Partner’s quality  network, said Dr. Chuck Pu, a medical director at Partners. This fall, Partners dropped one of  its own nursing homes from its preferred list after it got a poor inspection. “There’s no free  pass,” Pu said.

More careful attention to nursing home quality has been encouraged by existing financial  incentives created by the Affordable Care Act that cut payments to hospitals if too many  patients are readmitted within a month. “The whole idea of preferred provider networks is  really going to escalate in the future,” said Brian Fuller, an executive with NaviHealth, a  consulting company for hospitals that focuses on patient care after discharge.

Foster, the hospital association executive, said the proposed Medicare rule should make  hospitals less wary about giving more detailed guidance. “This signals that it’s okay for  knowledgeable folks to really engage in that conversation with patients and their families,”  Foster said.

New drug limits and then repairs brain damage in stroke

Date:November 25, 2016 Source:Manchester University Summary:A potential new drug reduces the number of brain cells destroyed by stroke and then helps to repair the damage, researchers have discovered.

A reduction in blood flow to the brain caused by stroke is a major cause of death and disability, and there are few effective treatments.

A team of scientists at The University of Manchester has now found that a potential new stroke drug not only works in rodents by limiting the death of existing brain cells but also by promoting the birth of new neurons (so-called neurogenesis).

This finding provides further support for the development of this anti-inflammatory drug, interleukin-1 receptor antagonist (IL-1Ra in short), as a new treatment for stroke. The drug is already licensed for use in humans for some conditions, including rheumatoid arthritis. Several early stage clinical trials in stroke with IL-1Ra have already been completed in Manchester, though it is not yet licensed for this condition.

In the research, published in the biomedical journal Brain, Behavior and Immunity, the researchers show that in rodents with a stroke there is not only reduced brain damage early on after the stroke, but several days later increased numbers of new neurons, when treated with the anti-inflammatory drug IL-1Ra.